Chateal Eq Kit
Product Images NDC 50102-230

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Chateal Eq (NDC 50102-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Levo Ethi Fig1)

A horizontal bar chart illustrating the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC (1 to 5 cases), COC-User (3 to 9 cases), Pregnancy (5 to 20 cases), and Postpartum (12 weeks only) with the highest range (40 to 65 cases). A note clarifies pregnancy data is based on actual pregnancy duration from reference studies, assuming a nine-month duration.*

FDA Label Image

Figure-2 (Levo Ethi Fig2)

A forest plot chart showing effect estimates from several studies comparing ever combined oral contraceptive (COC) use versus never use, and current COC use versus never use. The plot displays odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals for each study listed, illustrating the variation in effect estimates around a reference line at 1.00.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (28 Tablets Pouch))

Illustration showing a vertical arrow labeled 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom, with pregnancy rates per 100 women per year listed on the left. Different birth control methods are categorized on the right: Implants, injections, intrauterine devices, and sterilization at the top (fewer pregnancies); birth control pills, skin patch, vaginal ring with hormones in the middle; condoms and diaphragm below that; and no sex during fertile days, spermicide, withdrawal, and no birth control at the bottom (more pregnancies).*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (84 Tablets Carton))

An instructional diagram labeled Figure A showing a 28-day medication schedule for Chateal EQ (Levonorgestrel and Ethinyl Estradiol) tablets. It is organized in four weekly rows with circles for each day from Sunday to Saturday, noting color instructions (Orange for weeks 1-3 and Green for week 4). The diagram includes the NDC 50102-230-01 and storage temperature guidance at 20 to 25°C (68 to 77°F).*

FDA Label Image

Levo Ethi Fig5

Packaging label for Chateal EQ Kit containing Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg. The label states it includes 21 orange tablets with active ingredients and 7 green inert tablets, totaling 28 tablets. Manufactured by Afaxys Pharma, LLC, the label includes use instructions and sealing area marks.*

FDA Label Image

Levo Ethi Fig6

Chateal EQ kit containing Levonorgestrel and Ethinyl Estradiol tablets USP, each tablet 0.15 mg/0.03 mg. The packaging shows 3 pouches of 28 tablets each, with 21 orange active tablets and 7 green inert tablets per pouch. Labeler is Afaxys Pharma, LLC, with manufacturing by Aurobindo Pharma Limited, Product of India. The box includes standard regulatory and dosage information.*

FDA Label Image

Levo Ethi Str1

Chemical structure of Levonorgestrel, showing its molecular formula C21H28O2 and molecular weight 312.4. The diagram depicts the arrangement of atoms within the Levonorgestrel molecule.*

FDA Label Image

Levo Ethi Str2

Chemical structure diagram of Ethinyl Estradiol, showing its molecular framework with labeled hydroxyl and ethynyl functional groups, molecular formula C20H24O2, and molecular weight 296.4.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.